This guideline covers long-acting reversible contraception. It aims to increase the use of long-action reversible contraception by improving the information given to women about their contraceptive choices.
In September 2014, we reviewed the evidence for progestogen-only subdermal implants and updated the recommendations in section 1.5.
This guideline includes recommendations on:
- contraception and principles of care
- copper intrauterine devices
- intrauterine system
- progestogen-only injectable contraceptives
- progestogen-only subdermal implants
Who is it for?
- Healthcare professionals
- Commissioners and providers
- Women who need contraception and their partners, families and carers
Is this guideline up to date?
This guideline will shortly be checked to see if it needs updating.
We plan to publish our decision on whether the guideline should be updated in May 2017.
Register as a stakeholder to be informed about the decision.
Guideline development process
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.